会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • MULTILAYER LYOPHILE FOR PREPARING RADIOPHARMACEUTICALS
    • 用于制备放射线显微镜的多层LYOPHILE
    • WO1995016469A1
    • 1995-06-22
    • PCT/IB1994000390
    • 1994-12-05
    • BRACCO INTERNATIONAL B.V.
    • BRACCO INTERNATIONAL B.V.NOWOTNIK, David, P.
    • A61K51/12
    • A61K51/0497A61K51/1258
    • The present invention is directed to a stable multilayer lyophile having a radioligand in a first layer and at least one other layer having at least one component which is chemically incompatible with the radioligand in the first layer. The invention also comprises an optional interface layer. The multilayer lyophile provides a number of advantages. First, it allows incompatible ingredients to be contained in separate layers in a single vial. Secondly, it is easier to use because less manipulation is required as compared to a multicontainer kit. Thirdly, less raw materials are required for manufacture because only one package, one label, etc., is needed. Finally, there is increased manufacturing efficiency because only one freeze drying run is needed to prepare the product.
    • 本发明涉及在第一层中具有放射性配体的稳定的多层冻干制品和至少一种具有至少一种在第一层中与放射性配体化学不相容的组分的其它层。 本发明还包括可选接口层。 多层冻干提供了许多优点。 首先,它允许不相容的成分包含在单个小瓶中的单独层中。 其次,使用更容易,因为与多容器套件相比,需要较少的操作。 第三,制造需要较少的原材料,因为只需要一个包装,一个标签等。 最后,提高制造效率,因为只需要一次冷冻干燥来制备产品。
    • 10. 发明申请
    • MAGNETICALLY LABELED CHEMOATTRACTANTS AS TARGETED CONTRAST AGENTS IN THE NMR IMAGING OF LIVING TISSUES
    • 作为生物组织核磁共振成像中靶向对比剂的磁性标记化学试剂
    • WO1997014443A1
    • 1997-04-24
    • PCT/IB1996001103
    • 1996-10-18
    • BRACCO INTERNATIONAL B.V.
    • BRACCO INTERNATIONAL B.V.TWEEDLE, Michael, F.KUMAR, KrishanEATON, Stephen
    • A61K49/00
    • A61K49/14A61K49/085A61K49/1839A61K49/1866A61K49/1896A61K51/088
    • The present invention addresses magnetically labeled chemoattractants, e.g. chemotactic peptides, for the detection and investigation of diseased or disordered tissue sites or organs in the body of human and animal patients. The chemotactic peptides have the general formula: N(X)-Y-Leu-Phe-Z-A-W wherein (X) is H or a protective group such as formyl, acetyl, t-Boc, or the like; Y is Nle or Met; Z is a chemical bond, an aminoacid or an oligopeptide, e.g. (N( gamma ))Lys, Ile, Asp, Nle-Tyr-Lys, or (Gly)n, n being 1 to 4; A is a linker; and W is a suitably derivatized paramagnetic macrocyclic chelate or magnetic particle. The invention also concerns physiologically acceptable administrable compositions or formulations comprising the labeled chemoattractants, methods for preparing the chemoattractants and the formulations, and methods of using the formulations for detecting, localizing and diagnosing infected or inflammatory sites, or other trauma in the organism.
    • 本发明涉及磁性标记的化学引诱物,例如 趋化肽,用于检测和调查人和动物患者体内的病变或无序组织部位或器官。 趋化肽具有以下通式:N(X)-Y-Leu-Phe-Z-A-W其中(X)为H或保护基如甲酰基,乙酰基,t-Boc等; Y是Nle或Met; Z是化学键,氨基酸或寡肽,例如。 (N(γ))Lys,Ile,Asp,Nle-Tyr-Lys或(Gly)n,n为1至4; A是一个连接符; W是适当衍生的顺磁性大环螯合物或磁性颗粒。 本发明还涉及生理上可接受的可施用的组合物或包含标记的化学引诱物的制剂,用于制备化学引诱物和制剂的方法,以及使用该制剂用于检测,定位和诊断感染或炎症部位或生物体中的其他创伤的方法。